2023 international evidence-based guideline pcos glp-1 receptor agonist 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿 𝗔𝗴𝗼𝗻𝗶𝘀𝘁𝘀 𝗼𝗻 𝗚𝗹𝘆𝗰𝗮𝘁𝗲𝗱 𝗛𝗲𝗺𝗼𝗴𝗹𝗼𝗯𝗶𝗻 𝗟𝗲𝘃𝗲𝗹𝘀 ⁣ ⁣ Randomized, placebo-controlled trials of the glucagon-like peptide-1 (GLP-1) agonists have provided strong Polycystic ovary syndrome: An update

The GLP-1 activity does not work alone

It is believed that Ozempics stimulation of GLP-1 receptors may cause a temporary delay in gastric emptying

Toujeo specifically enters the picture when a patient needs basal insulin and either has already tried and failed GLP-1 therapy, has a contraindication to GLP-1 drugs, has Type 1 diabetes, or has very advanced Type 2 diabetes with negligible beta cell function

Pharmacotherapy for obesity: what you need to know

The ongoing trends include a growing use of oral formulations of GLP-1 together with long-acting injectables, integration of digital health tools for adherence, and a focused approach to real-world evidence studies that provide long-term outcomes

Recent attention in the field of glucagon research has highlighted its potential for inducing weight loss in obese patients through mechanisms like lipolysis, thermogenesis, and enhanced energy metabolism [103]